• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦素在慢性丙型肝炎患者脂肪变性和纤维化严重程度的判定中不起作用。

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

作者信息

Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, Risso D, Lantieri P B, Icardi G, Barreca T, Testa R

机构信息

Department of Internal Medicine, University of Genoa, Italy.

出版信息

Am J Gastroenterol. 2000 Nov;95(11):3211-7. doi: 10.1111/j.1572-0241.2000.03294.x.

DOI:10.1111/j.1572-0241.2000.03294.x
PMID:11095344
Abstract

OBJECTIVE

The presence of steatosis is a common histological finding in patients with chronic hepatitis C (CHC). The causes of the severity of this condition are not yet clear, although both metabolic and viral factors supposedly are involved. In this study our aim was to examine the possible influence that leptin levels, hepatitis C virus (HCV) RNA levels, and hepatitis G virus (HGV) infection have on the severity of steatosis and on the presence and degree of fibrosis in patients with CHC.

METHODS

One hundred eighty-two CHC patients with histological findings of steatosis were chosen from among a cohort of patients referred to our center for staging of liver disease. Among them 48 CHC patients were accurately selected so as to rule out possible confounding factors for the presence of steatosis (diabetes mellitus, hyperlipemia, obesity, alcohol). Leptin levels, HCV RNA levels, and HCV genotype, and the presence of HGV RNA were assessed in these patients and related to histological findings.

RESULTS

We found that leptin levels in CHC patients were similar to those in healthy subjects. No relationship was found between leptin levels and severity of steatosis. HCV RNA levels, HCV genotype, and the presence of HGV infection were no different among CHC patients with various degrees of steatosis. Leptin was not related to different degrees of fibrosis, whereas higher viral load was the only parameter associated to higher fibrosis scores.

CONCLUSIONS

These findings suggest that the degree of steatosis in patients with CHC does not seem to depend on serum leptin levels or on viral factors, at least as far as HCV viremia and genotype and HGV infection are concerned. The severity of fibrosis does not seem to be influenced by leptin levels, whereas HCV viral load does seem to play some role.

摘要

目的

脂肪变性是慢性丙型肝炎(CHC)患者常见的组织学表现。尽管代谢和病毒因素可能都与之相关,但这种情况严重程度的病因尚不清楚。在本研究中,我们的目的是探讨瘦素水平、丙型肝炎病毒(HCV)RNA水平和庚型肝炎病毒(HGV)感染对CHC患者脂肪变性严重程度以及纤维化的存在和程度可能产生的影响。

方法

从转诊至我们中心进行肝病分期的患者队列中选取182例有脂肪变性组织学表现的CHC患者。其中准确挑选出48例CHC患者,以排除脂肪变性存在的可能混杂因素(糖尿病、高脂血症、肥胖、酒精)。对这些患者评估瘦素水平、HCV RNA水平、HCV基因型以及HGV RNA的存在情况,并将其与组织学结果相关联。

结果

我们发现CHC患者的瘦素水平与健康受试者相似。未发现瘦素水平与脂肪变性严重程度之间存在关联。不同程度脂肪变性的CHC患者之间,HCV RNA水平、HCV基因型以及HGV感染情况并无差异。瘦素与不同程度的纤维化无关,而较高的病毒载量是与较高纤维化评分相关的唯一参数。

结论

这些发现表明,CHC患者的脂肪变性程度似乎不取决于血清瘦素水平或病毒因素,至少就HCV病毒血症、基因型和HGV感染而言是这样。纤维化的严重程度似乎不受瘦素水平影响,而HCV病毒载量似乎确实起了一定作用。

相似文献

1
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.瘦素在慢性丙型肝炎患者脂肪变性和纤维化严重程度的判定中不起作用。
Am J Gastroenterol. 2000 Nov;95(11):3211-7. doi: 10.1111/j.1572-0241.2000.03294.x.
2
Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.非酒精性脂肪性肝炎和慢性丙型肝炎中的瘦素水平。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2422-5.
3
Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.血清瘦素水平与慢性丙型肝炎中的肝脂肪变性相关。
Am J Gastroenterol. 2003 May;98(5):1135-41. doi: 10.1111/j.1572-0241.2003.07450.x.
4
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.慢性丙型肝炎中的胰岛素抵抗:与1型和4型基因型、血清丙型肝炎病毒RNA水平及肝纤维化的关系
Gastroenterology. 2008 Feb;134(2):416-23. doi: 10.1053/j.gastro.2007.11.010. Epub 2007 Nov 12.
5
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.慢性肝病患者血清脂肪因子水平:抵抗素水平与肝纤维化严重程度的关联
Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.
6
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.肝脂肪变性会加速慢性丙型肝炎患者肝脏损伤的进展,且与特定的丙肝病毒基因型及内脏肥胖相关。
Hepatology. 2001 Jun;33(6):1358-64. doi: 10.1053/jhep.2001.24432.
7
Hepatic steatosis in Iranian patients with chronic hepatitis C.伊朗慢性丙型肝炎患者的肝脂肪变性
Med Princ Pract. 2008;17(2):126-30. doi: 10.1159/000112966. Epub 2008 Feb 19.
8
Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.丙型肝炎病毒相关的低β脂蛋白血症与血浆病毒载量、脂肪变性和肝纤维化相关。
Am J Gastroenterol. 2003 May;98(5):1150-4. doi: 10.1111/j.1572-0241.2003.07402.x.
9
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.慢性丙型肝炎中脂肪变性、炎症和纤维化之间的关系:个体患者数据的荟萃分析
Gastroenterology. 2006 May;130(6):1636-42. doi: 10.1053/j.gastro.2006.03.014.
10
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.胰岛素抵抗和糖尿病会增加1型丙型肝炎病毒感染患者肝脏的纤维化程度。
Am J Gastroenterol. 2008 May;103(5):1136-44. doi: 10.1111/j.1572-0241.2008.01813.x.

引用本文的文献

1
P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis.P2X4 受体介导抗氧化剂、纤维生成细胞因子和 ECM 转录物的诱导;在体外存在复制的 HCV 的情况下:对 P2X4 在纤维化中的作用的深入了解。
PLoS One. 2022 May 20;17(5):e0259727. doi: 10.1371/journal.pone.0259727. eCollection 2022.
2
Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases.解析瘦素在肝功能中的作用及其与肝脏疾病的关系。
Int J Mol Sci. 2020 Dec 9;21(24):9368. doi: 10.3390/ijms21249368.
3
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.
脂肪细胞因子在消化疾病中的作用:炎症、代谢改变和疾病进展的标志物。
Int J Mol Sci. 2020 Nov 5;21(21):8308. doi: 10.3390/ijms21218308.
4
Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity.丙型肝炎病毒清除患者中瘦素与补体的关联:代谢与免疫的稳态
PLoS One. 2016 Nov 21;11(11):e0166712. doi: 10.1371/journal.pone.0166712. eCollection 2016.
5
Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis.丙型肝炎病毒肝脂肪变性中的脂肪因子、细胞因子与体脂储存
World J Hepatol. 2016 Jan 8;8(1):74-82. doi: 10.4254/wjh.v8.i1.74.
6
Liver steatosis in hepatitis C patients.丙型肝炎患者的肝脂肪变性
World J Hepatol. 2015 Jun 8;7(10):1337-46. doi: 10.4254/wjh.v7.i10.1337.
7
Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.血清瘦素和脂联素水平在埃及慢性丙型肝炎病毒相关性肝脂肪变性和肝纤维化患者中的意义
World J Hepatol. 2013 Feb 27;5(2):74-81. doi: 10.4254/wjh.v5.i2.74.
8
Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.瘦素、脂联素和三种新型脂肪因子——内脏脂肪素、趋化素和 vaspin——在慢性肝炎中的潜在作用。
Mol Med. 2011;17(11-12):1397-410. doi: 10.2119/molmed.2010.00105. Epub 2011 Jul 5.
9
Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.丙型肝炎病毒4型患者接受干扰素治疗后脂肪变性的改善与体重减轻有关。
Indian J Gastroenterol. 2009 Mar-Apr;28(2):45-8. doi: 10.1007/s12664-009-0016-1. Epub 2009 Aug 21.
10
Adipocytokines and liver disease.脂肪细胞因子与肝脏疾病
J Gastroenterol. 2008;43(11):811-22. doi: 10.1007/s00535-008-2213-6. Epub 2008 Nov 18.